Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome SESPB for postoperative analgesia in mixed hemorrhoid surgery
ChiCTR2500106416Phase 4Not yet recruiting
- Sponsor
- Fuyang People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine in hemorrhoid (2 arms), sponsored by Fuyang People's Hospital. Primary endpoints: Postoperative VAS pain scores, VAS score at first dressing change after surgery and 2 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2500106416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106416.